Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (NYSE: HUM) is a U.S. healthcare company in the direct health and medical insurance carriers industry, with operations spanning insurance services and CenterWell health care services. News about Humana often centers on its Medicare Advantage and Medicaid activities, partnerships that expand care models, and initiatives that address social determinants of health and health equity.
Recent announcements highlight Humana’s focus on Medicare Advantage, including earnings guidance updates and investor communications disclosed through Form 8-K filings, as well as program-specific developments such as Humana USAA Honor Giveback plans that are designed with veterans’ needs in mind. These co-branded Medicare Advantage plans feature benefits like $0 copays for in-network primary care and in-network mental health services, Part B givebacks and coverage for dental, vision and hearing, while remaining available to any eligible Medicare beneficiary in the covered areas.
Humana news also reflects its emphasis on value-based care and integrated support for complex conditions. The company has announced a partnership with Atlas Oncology Partners to offer a coordinated oncology care model for eligible Humana Medicare Advantage members in Tennessee and Mississippi, bringing together interdisciplinary care teams, care coordination, psychosocial support and advanced supportive care. In parallel, CenterWell Senior Primary Care and Conviva Senior Primary Care have partnered with Thyme Care to provide continuous, oncology-focused support to eligible patients across several states.
Beyond insurance and clinical partnerships, Humana-related coverage includes updates from the Humana Foundation on research into loneliness among underserved boys and food insecurity among seniors, as well as community impact awards through Humana Healthy Horizons in Oklahoma to organizations addressing food, housing and employment needs. Visitors to this page can explore earnings-related updates, ratings actions from agencies such as AM Best, leadership transitions, philanthropic reports and community initiatives that illustrate how Humana combines insurance, care delivery and community investment.
Humana Inc. (NYSE: HUM) has transitioned its pharmacy services to the CenterWell brand, now encompassing CenterWell Pharmacy and CenterWell Specialty Pharmacy. This change reflects a commitment to enhancing patient-centered care and ensuring reliable pharmacy services. The new branding aims to streamline care experiences, providing holistic and personalized healthcare options. Existing services like Enclara Pharmacia and Humana Pharmacy Solutions will retain their original branding. This brand evolution is part of Humana's broader strategy to integrate healthcare services and improve health outcomes.
Humana Inc. (NYSE: HUM) is expanding its onehome value-based home care model to Virginia, enhancing services for Medicare Advantage members. This initiative aims to streamline in-home care through local providers, addressing a significant need for integrated healthcare. Notably, Humana anticipates adding approximately 220 jobs in Virginia and North Carolina. The expansion follows their acquisition of Kindred at Home, making Humana the largest provider of home care services in the U.S. The goal is to have 50% of Medicare Advantage members access this model within five years.
The Foundation for Social Connection and Humana will host Conversations on Belonging, Connection, & Wellbeing during Global Loneliness Awareness Week (June 13-17). Scheduled for June 15 at the U.S. Capitol Visitors Center, the event features U.S. Surgeon General Vivek Murthy and Jenna Bush Hager. The initiative addresses the rising issue of loneliness, emphasizing its health impacts and promoting social connection. Humana aims to elevate awareness through its "Far From Alone" campaign, collaborating with industry leaders to foster belonging and improve mental health.
Humana Inc. (NYSE: HUM) has announced the expansion of its rebranding initiative for the home health division of Kindred at Home (KAH), now transitioning to CenterWell Home Health. This Phase 2 addition includes 14 new states, bringing the total to 21 states involved in the transition. The initiative follows Humana's acquisition of KAH in August 2021 and aims to enhance home-based healthcare services. Phase 3 is set for early September, with operations in an additional 17 states expected to transition, ultimately covering over 350 locations across 38 states.
Humana Inc. (NYSE: HUM) announced that CFO Susan M. Diamond will present at the Jefferies Healthcare Conference on June 8, 2022, at 11:30 a.m. Eastern time. A live audio webcast will be available on Humana's Investor Relations page, with participants advised to log in 15 minutes early for system checks. Humana is dedicated to enhancing health outcomes through integrated care and support for healthcare professionals, focusing on Medicare members and various communities. For more information, visit humana.com.
Humana Inc. (NYSE: HUM) has partnered with Welsh, Carson, Anderson & Stowe to establish a new joint venture, allocating up to
Humana Specialty Pharmacy has been awarded the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the fifth consecutive year, highlighting its strong commitment to customer satisfaction and patient care. The award reflects the dedication of its staff, including pharmacists and care coordinators, in providing personalized care. Humana Specialty Pharmacy offers 24-hour access to pharmacists and supports patients applying for assistance programs for specialty drugs. Humana Inc. (NYSE: HUM) aims to improve health outcomes for its members through integrated care solutions.
Humana Inc. (NYSE: HUM) announced that CFO Susan M. Diamond will present at the BofA Securities Healthcare Conference on May 10, 2022, at 9:20 a.m. Pacific time. A live audio webcast will be accessible through Humana’s Investor Relations page, with participants encouraged to log in 15 minutes early for setup. Humana focuses on integrated care to improve health outcomes and lower costs for members, offering services in in-home care, behavioral health, and more. Additional information is available at humana.com.
Humana reported strong 1Q22 earnings with a GAAP EPS of $7.29 and an Adjusted EPS of $8.04, both exceeding previous year figures. The company raised FY 2022 EPS guidance to approximately $22.98 on a GAAP basis and $24.50 on an Adjusted basis, reflecting a 19% growth from FY 2021, despite a COVID-19 headwind. Humana anticipates membership growth of 150,000 to 200,000 in Medicare Advantage for FY 2022 and has introduced a $1 billion value creation initiative to enhance services. Total revenues rose to $23.97 billion from $20.67 billion year-over-year.
Humana Inc. has entered into a definitive agreement to divest a 60% interest in its Hospice and Personal Care divisions of Kindred at Home to Clayton, Dubilier & Rice for approximately $2.8 billion. This transaction reflects a valuation of $3.4 billion and a multiple of about 12 times the divisions’ forecasted Adjusted EBITDA. The move aligns with Humana's strategy to offload non-core segments while still maintaining a minority interest. Proceeds will be used for debt repayment and share repurchases, with no significant impact on 2022 earnings expected.